The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice

Cancer Research

Volumn 60, Issue 17, 2000, Pages 4913-4920

  Xu, F ^a   Xia, W ^a   Luo, R Z ^a   Peng, H ^a   Zhao, S ^a   Dai, J ^a   Long, Y ^a   Zou, L ^a   Le, W ^a   Liu, J ^a   Parlow, A F ^a   Hung, M C ^a   Bast R C , Jr ^a   Yu, Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PROLACTIN;

ANIMAL CELL; ARTICLE; CLONOGENIC ASSAY; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; LACTATION; MOUSE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR DOWN REGULATION; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; BODY WEIGHT; CYTOMEGALOVIRUS; ESTRADIOL; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; GROWTH HORMONE; GROWTH INHIBITORS; LACTATION DISORDERS; MALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; OVARY; PHENOTYPE; POSTPARTUM PERIOD; PREGNANCY; PROGESTERONE; PROLACTIN; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RHO GTP-BINDING PROTEINS;

EID: 0034282543     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas
2. ARHI is the center of allelic deletion on chromosome Ip31 in ovarian and breast cancers
3. Expression of a refinoblastoma transgene results in dwarf mice
4. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse
5. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
6. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities
7. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene
8. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma
9. Kinetic PCR: Real-time monitoring of DNA amplification reactions
10. The cytomegalovirus enhancer: A pan-active control element in transgenic mice
11. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys
12. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration
13. Prolactin (PRL) and its receptor: Actions, signal transducfion pathways and phenotypes observed in PRL receptor knockout mice
14. Possible role of transforming growth factor-β as a mediator of luteotropic action of prolactin in rat luteal cell cultures
15. Prolactin as a factor in the uterine response to progesterone in rabbits
16. Differences in the rabbit uterine response to progesterone as influenced by growth hormone or prolactin
17. Insights from the study of animals lacking functional estrogen receptor
18. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice
19. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture
20. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells
21. Extrapituitary prolactin: Distribution, regulation, functions and clinical aspects
22. Targeted disruption of the estrogen receptor gene in male mice cause alteration of spermatogenesis and infertility
23. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development